Share Email Print
cover

Proceedings Paper

Novel 2DG-based harmine derivatives for targeted cancer therapy
Author(s): Aqin Wang; Yuqi Chen; Wei R. Chen; Yueqing Gu
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Harmine is a beta-carboline alkaloid from the plant Peganum harmala. These alkaloids were stimulated by their promising antitumor activities in the recent years. In this study, we designed and synthesized two harmine derivatives #1and #2 modified at position-9 of harmine with ethyl and phenylpropyl, respectively. To improve the tumor targeting capability, #1’ and #2’ were synthesized by conjugating 2-amino-2-deoxy-D-glucose (2DG) to the derivatives #1 and #2, respectively. The MTT assays of all these compounds in vitro against L02, HepG2 showed all compounds had low toxicity to normal cells (L02) and significantly enhanced carcinoma cell inhibitory rate compared to harmine. Cytotoxicity against liver cancer cell lines of compound #1’ #2’ is higher than #1 #2, and even the compound #2’ is better than positive drug 5-FU. The compound #2’, a novel 2DG-based harmine derivatives, could become a promising drug for targeted cancer therapy and combination therapy with other antitumor drugs.

Paper Details

Date Published: 21 February 2013
PDF: 7 pages
Proc. SPIE 8582, Biophotonics and Immune Responses VIII, 85820V (21 February 2013); doi: 10.1117/12.2003268
Show Author Affiliations
Aqin Wang, China Pharmaceutical Univ. (China)
Yuqi Chen, China Pharmaceutical Univ. (China)
Wei R. Chen, Univ. of Central Oklahoma (United States)
Yueqing Gu, China Pharmaceutical Univ. (China)


Published in SPIE Proceedings Vol. 8582:
Biophotonics and Immune Responses VIII
Wei R. Chen, Editor(s)

© SPIE. Terms of Use
Back to Top